News
NTAGI Approves Serum Institute of India's Covovax for the 12-17 Age Group: Sources ... - Latest Tweet by ANI
The latest Tweet by ANI states, 'NTAGI approves Serum Institute of India's Covovax for the 12-17 age group: Sources #COVID19'
NTAGI approves Serum Institute of India's Covovax for the 12-17 age group: Sources #COVID19 pic.twitter.com/v84yzEAEMA— ANI (@ANI) April 29, 2022
(The above story first appeared on LatestLY on Apr 29, 2022 05:21 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
